Documents

Discussions Technicals Forecast Seasonals Options

Keros Therapeutics, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Keros Therapeutics, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Data partner

Description

Reported date

Form

2025

Q2 2025

Aug 06, 2025

Earnings release8-K

Quarterly report10-Q

Q1 2025

May 06, 2025

Quarterly report10-Q

Earnings release8-K

Status Update

Mar 31, 2025

Press release

Slides

Guggenheim SMID Cap Biotech Conference

Feb 06, 2025

Transcript

Investor Presentation

Jan 29, 2025

Slides

2024

Q4 2024

Feb 26, 2025

Annual report10-K

Earnings release8-K

Q3 2024

Nov 06, 2024

Quarterly report10-Q

Earnings release8-K

Q2 2024

Aug 07, 2024

Quarterly report10-Q

Earnings release8-K

Status Update

Jun 17, 2024

Press release

Q1 2024

May 08, 2024

Quarterly report10-Q

Earnings release8-K

2023

Q4 2023

Feb 28, 2024

Annual report10-K

Earnings release8-K

Study Update

Dec 11, 2023

Press release

Slides

Corporate Presentation

Nov 10, 2023

Slides

Q3 2023

Nov 06, 2023

Quarterly report10-Q

Earnings release8-K

Investor Presentation

Aug 08, 2023

Slides

Q2 2023

Aug 07, 2023

Quarterly report10-Q

Earnings release8-K

Q1 2023

May 04, 2023

Quarterly report10-Q

Earnings release8-K

2022

Q4 2022

Mar 03, 2023

Earnings release8-K

Q3 2022

Nov 03, 2022

Quarterly report10-Q

Earnings release8-K

Q2 2022

Aug 04, 2022

Quarterly report10-Q

Earnings release8-K

Q1 2022

May 05, 2022

Quarterly report10-Q

Earnings release8-K

2021

Q4 2021

Mar 09, 2022

Earnings release8-K

Annual report10-K

Q3 2021

Nov 04, 2021

Quarterly report10-Q

Earnings release8-K

Q2 2021

Aug 05, 2021

Quarterly report10-Q

Earnings release8-K

Q1 2021

May 06, 2021

Quarterly report10-Q

Earnings release8-K

2020

Q4 2020

Mar 25, 2021

Annual report10-K